EMA warns of risk to babies from fathers taking epilepsy drug 

The European Medicines Agency say that children born to men prescribed medicine containing epilepsy drug valproate, may have an increased risk of neurodevelopmental disorders.

The European Medicines Agency has said men who use prescribed medicine containing valproate should discuss contraception with their doctors as it could pose a risk to babies.

The EMA said the drug could pose “a potential increased risk of neurodevelopmental disorders in children born to men treated with valproate during the three months before conception”.